Position in ZTS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$106,722,232
-$248,404,250 QoQ
Shares Held
1,485,141
-50.6% QoQ
Ownership
0.359%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#54
of 1,408 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swedbank AB holds $548,199,348 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
322,995 | $175,008,380 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
1,201,243 | $133,265,898 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
651,082 | $109,733,360 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
1,485,141 | $106,722,232 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
391,175 | $13,253,008 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
249,000 | $10,216,470 |
All Filings in ZTS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106,722,232 | 1,485,141 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $355,126,482 | 3,004,200 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $344,066,113 | 2,734,590 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $356,565,452 | 2,436,888 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $236,933,275 | 1,519,290 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $312,051,682 | 1,915,250 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $354,051,224 | 1,812,116 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $337,406,580 | 1,946,277 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $210,815,185 | 1,245,879 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $186,592,019 | 945,392 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $124,202,582 | 713,890 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $34,025,424 | 197,581 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $32,174,682 | 193,311 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $30,090,085 | 205,323 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $31,178,713 | 210,255 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $35,438,217 | 206,168 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $46,027,463 | 244,061 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $57,564,480 | 235,891 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $46,459,449 | 239,309 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $44,921,891 | 241,049 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $36,099,770 | 229,234 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||